Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study

46Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Exposures to polycyclic aromatic hydrocarbons (PAHs) from various environmental and occupational sources are considered a primary risk factor for lung cancer among lifelong never smokers, based largely on results from epidemiologic studies utilizing selfreported exposure information. Prospective, biomarker-based human studies on the role of PAH and other airborne carcinogens in the development of lung cancer among lifelong non-smokers have been lacking. We prospectively investigated levels of urinary metabolites of a PAH and volatile organic compounds in relation to lung cancer risk in a nested case-control study of 82 cases and 83 controls among lifelong never smokers of the Shanghai Cohort Study, a prospective cohort of 18 244 Chinese men aged 45-64 years at enrollment. We quantified three PAH metabolites: r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (PheT), 3-hydroxyphenanthrene (3-OH-Phe) and total hydroxyphenanthrenes (total OH-Phe, the sum of 1-, 2-, 3- and 4-OH-Phe), as well as metabolites of the volatile organic compounds acrolein (3-hydroxypropyl mercapturic acid), benzene (S-phenyl mercapturic acid), crotonaldehyde (3-hydroxy-1-methylpropylmercapturic acid) and ethylene oxide (2-hydroxyethyl mercapturic acid). Urinary cotinine was also quantified to confirm non-smoking status. Compared with the lowest quartile, odds ratios (95% confidence intervals) for lung cancer risk for the highest quartile levels of PheT, 3-OH-Phe and total OH-Phe were 2.98 (1.13-7.87), 3.10 (1.12-7.75) and 2.59 (1.01-6.65) (all Ptrend < 0.05), respectively. None of the metabolites of the volatile organic compounds were associated with overall lung cancer risk. This study demonstrates a potentially important role of exposure to PAH in the development of lung cancer among lifelong never smokers. © The Author 2013. Published by Oxford University Press. All rights reserved.

References Powered by Scopus

Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air

1608Citations
N/AReaders
Get full text

Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma

654Citations
N/AReaders
Get full text

Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease

610Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Particulate matter air pollution components and risk for lung cancer

244Citations
N/AReaders
Get full text

Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: Results of a randomized clinical trial in China

156Citations
N/AReaders
Get full text

Biomarkers of tobacco exposure: Summary of an FDA-sponsored public workshop

106Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yuan, J. M., Butler, L. M., Gao, Y. T., Murphy, S. E., Carmella, S. G., Wang, R., … Hecht, S. S. (2014). Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study. Carcinogenesis, 35(2), 339–345. https://doi.org/10.1093/carcin/bgt352

Readers over time

‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘240481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

47%

Researcher 16

42%

Lecturer / Post doc 3

8%

Professor / Associate Prof. 1

3%

Readers' Discipline

Tooltip

Environmental Science 12

44%

Medicine and Dentistry 9

33%

Computer Science 3

11%

Chemistry 3

11%

Save time finding and organizing research with Mendeley

Sign up for free
0